X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (10) 10
female (10) 10
humans (10) 10
male (10) 10
middle aged (10) 10
double-blind method (5) 5
index medicus (5) 5
medicine, general & internal (5) 5
atrial fibrillation (4) 4
cardiovascular disease (4) 4
drug therapy (4) 4
drug therapy, combination (4) 4
mortality (4) 4
myocardial infarction - drug therapy (4) 4
stroke (4) 4
atrial fibrillation - complications (3) 3
cardiac & cardiovascular systems (3) 3
fibrinolytic agents - therapeutic use (3) 3
follow-up studies (3) 3
heart attacks (3) 3
management (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
myocardial infarction (3) 3
myocardial infarction - mortality (3) 3
risk (3) 3
stroke - prevention & control (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
acute coronary syndromes (2) 2
adult (2) 2
angina pectoris (2) 2
angina, unstable - drug therapy (2) 2
anticoagulants - adverse effects (2) 2
anticoagulants - therapeutic use (2) 2
antithrombotic therapy (2) 2
aspirin - therapeutic use (2) 2
atrial fibrillation - drug therapy (2) 2
clinical trials (2) 2
coronary artery disease (2) 2
embolism (2) 2
evaluation (2) 2
heart failure - drug therapy (2) 2
heart failure - etiology (2) 2
hemorrhage - chemically induced (2) 2
ischemia (2) 2
life sciences (2) 2
medical research (2) 2
medicin (2) 2
medicine (2) 2
myocardial infarction - complications (2) 2
myocardial-infarction (2) 2
recurrence (2) 2
risk factors (2) 2
stroke - epidemiology (2) 2
stroke - etiology (2) 2
survival analysis (2) 2
task-force (2) 2
therapy (2) 2
ventricular dysfunction, left - drug therapy (2) 2
ventricular dysfunction, left - etiology (2) 2
vitamin k - antagonists & inhibitors (2) 2
[ info.info-ts ] computer science [cs]/signal and image processing (1) 1
[ sdv.ib ] life sciences [q-bio]/bioengineering (1) 1
[ spi.signal ] engineering sciences [physics]/signal and image processing (1) 1
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
[sdv]life sciences [q-bio] (1) 1
ace (1) 1
ace inhibitors (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - blood (1) 1
acute coronary syndrome - complications (1) 1
acute coronary syndrome - drug therapy (1) 1
acute disease (1) 1
acute myocardial infarction (1) 1
acute myocardial-infarction (1) 1
aged, 80 and over (1) 1
american-college (1) 1
amigdalitis (1) 1
angina (1) 1
angina, unstable - mortality (1) 1
angina, unstable - therapy (1) 1
angina; unstable/drug therapy/mortality/therapy (1) 1
angioplasty, balloon, coronary (1) 1
angioplasty; transluminal; percutaneous coronary (1) 1
angiotensin ii receptor blockers (1) 1
angiotensin receptor antagonists (1) 1
angiotensin-converting enzyme inhibitors - adverse effects (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
anti-inflammatory agents, non-steroidal - therapeutic use (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
anticholesteremic agents - adverse effects (1) 1
anticholesteremic agents - therapeutic use (1) 1
anticoagulant therapy (1) 1
anticoagulants (1) 1
anticoagulants/adverse effects/therapeutic use (1) 1
anticoagulation control (1) 1
apolipoprotein b (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
by Sawhney, Jitendra Pal Singh and Sawhney, Jitendra PS and Sawhney, J.P.S and Kothiwale, V.A and Kothiwale, Veerappa A and Bisne, V and Bisne, Vikas and Durgaprasad, Rajashekhar and Durgaprasad, R and Jadhav, P and Jadhav, Praveen and Jadhav, S and Chopda, Manoj and Chopda, M and Vanajakshamma, V and Vanajakshamma, Velam and Meena, Ramdhan and Meena, R and Vijayaraghavan, Govindan and Vijayaraghavan, G and Chawla, Kamaldeep and Chawla, K and Allu, Jagan and Pieper, Karen S and John Camm, A and Kakkar, Sanjay and Kakkar, Ajay K and Kakkar, S and Bassand, Jean-Pierre and Fitzmaurice, D and Fitzmaurice, David and Fitzmaurice, David A and Goldhaber, S.Z and Goldhaber, Samuel Z and Goto, K and Goto, Shinya and Goto, T and Haas, Sylvia and Hacke, Werner and Mantovani, Lorenzo G and Misselwitz, Frank and Turpie, Alexander G.G and van Eickels, Martin and Verheugt, Freek W.A and Kayani, Gloria and Fox, B and Fox, R and Fox, Keith A.A and Gersh, Bernard J and Luciardi, Hector Lucas and Luciardi, H.L and Gibbs, J and Gibbs, Harry and Gibbs, H and Brodmann, Marianne and Brodmann, M and Cools, F and Cools, Frank and Barretto, A.C.P and Barretto, Antonio Carlos Pereira and Connolly, Stuart J and Connolly, S.J and Spyropoulos, Alex and Spyropoulos, A and Eikelboom, John and Eikelboom, J and Corbalan, R and Corbalan, Ramon and Hu, X.S and Hu, Dayi and Hu, D.Y and Jansky, Petr and Jansky, P and Nielsen, Jørn Dalsgaard and Nielsen, J and Nielsen, H and Ragy, H and Ragy, Hany and Raatikainen, Pekka and Raatikainen, P and Le Heuzey, J.-Y and Le Heuzey, Jean-Yves and Darius, H and Darius, Harald and Keltai, Matyas and Keltai, M and Agnelli, Giancarlo and Agnelli, G and Ambrosio, G and Ambrosio, Giuseppe and Koretsune, Yukihiro and Koretsune, Y and Sánchez Díaz, Carlos Jerjes and Sánchez Díaz, C.J and Ten Cate, Hugo and Atar, Dan and Atar, D and Stepinska, J and Stepinska, Janina and Panchenko, E and ... and GARFIELD-AF Investigators
Indian Heart Journal, ISSN 0019-4832, 11/2018, Volume 70, Issue 6, pp. 828 - 835
The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing... 
Arrhythmia | GARFIELD-AF | Atrial fibrillation | Anticoagulant therapy | Clinical and Preventive Cardiology
Journal Article